Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction
- PMID: 2009130
- DOI: 10.1002/mc.2940040104
Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction
Abstract
The human p53 gene, a putative tumor suppressor gene, has a polymorphism in amino acid residue 72. We recently developed a method of detecting codon 72 polymorphism in this gene by digestion of polymerase chain reaction-amplified DNA using an allele-specific restriction endonuclease. This polymorphism allows the identification of loss of heterozygosity for the coding region of the p53 gene in limited tissue samples in a short time without using radioactive materials. We examined 33 patients with renal cell carcinoma and 29 with bladder cancer; heterozygosity in the p53 gene was lost in 60% (6 of 10 cases) and 73% (8 of 11 cases) of the renal and bladder tumors, respectively. Additionally, the assay's sensitivity could be improved by using DNA extracted from frozen sections of the tumors. Because the proportions of tumor cells and nontumor cells could be assessed by microscopic evaluation of the frozen sections, we were able to minimize contamination from nontumor cells, which occasionally causes false readings of retained heterozygosity. This simple and sensitive method for detecting loss of heterozygosity in the p53 gene makes it possible to rapidly screen a large number of tissue samples and has the potential to be a useful diagnostic tool for a wide variety of human neoplasms.
Similar articles
-
Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.J Urol. 2008 Aug;180(2):724-8. doi: 10.1016/j.juro.2008.03.183. Epub 2008 Jun 13. J Urol. 2008. PMID: 18554638
-
Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.J Urol. 1993 Oct;150(4):1298-301. doi: 10.1016/s0022-5347(17)35764-6. J Urol. 1993. PMID: 8103806
-
Chromosome 17p deletions and p53 mutations in renal cell carcinoma.Cancer Res. 1993 Jul 1;53(13):3092-7. Cancer Res. 1993. PMID: 8319216
-
[Detection of codon 72 polymorphism of p53 gene from blood and loss of heterozygosity in brain tumors using polymerase chain reaction].No To Shinkei. 1993 Jan;45(1):43-7. No To Shinkei. 1993. PMID: 8476653 Japanese.
-
Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.Cancer Res. 1994 Apr 1;54(7 Suppl):1934s-1938s. Cancer Res. 1994. PMID: 7907948 Review.
Cited by
-
The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects.Indian J Dermatol. 2013 May;58(3):175-80. doi: 10.4103/0019-5154.110823. Indian J Dermatol. 2013. PMID: 23723465 Free PMC article.
-
Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance.World J Urol. 1996;14(3):190-6. doi: 10.1007/BF00186899. World J Urol. 1996. PMID: 8806198 Review.
-
Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.Br J Cancer. 1993 Mar;67(3):551-9. doi: 10.1038/bjc.1993.101. Br J Cancer. 1993. PMID: 8094976 Free PMC article.
-
Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases.Virchows Arch. 2004 Sep;445(3):292-7. doi: 10.1007/s00428-004-1041-1. Epub 2004 Jul 10. Virchows Arch. 2004. PMID: 15248064
-
Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.Jpn J Cancer Res. 1995 Aug;86(8):730-6. doi: 10.1111/j.1349-7006.1995.tb02461.x. Jpn J Cancer Res. 1995. PMID: 7559095 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous